HIF1A and head and neck squamous cell carcinoma: On the other hand, some HNSCC cell lines overexpressing HIF-1α are more sensitive to Cetuximab, an effect that appears to be strongly cell line-dependent [172] and may not translate to in vivo conditions in tumours.